Shoulder Innovations Q2 revenue $11M (+33% YoY); FY2025 guidance $42-44M

SHOULDER INNOVATIONS, INC.

Q2 net revenue $11.0M, up 33% YoY; gross margin 76.2% (vs 76.9%).
Net loss $19.2M vs $4.2M loss in Q2 2024, driven by $13.1M fair value charge on warrant liability and purchase option.
FY2025 revenue guidance $42M-$44M, implying ~33-39% growth over FY2024.
Raised $115M total gross proceeds from IPO ($75M) and convertible notes ($40M) in July/Aug 2025.
Appointed Rick Buchholz to board; launched InSet 70 humeral stem product.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.